"Cholestasis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).
| Descriptor ID |
D002779
|
| MeSH Number(s) |
C06.130.120.135
|
| Concept/Terms |
Cholestasis- Cholestasis
- Cholestases
- Biliary Stasis
- Biliary Stases
- Stases, Biliary
- Stasis, Biliary
- Bile Duct Obstruction
- Bile Duct Obstructions
- Duct Obstruction, Bile
- Duct Obstructions, Bile
- Obstruction, Bile Duct
- Obstructions, Bile Duct
|
Below are MeSH descriptors whose meaning is more general than "Cholestasis".
Below are MeSH descriptors whose meaning is more specific than "Cholestasis".
This graph shows the total number of publications written about "Cholestasis" by people in this website by year, and whether "Cholestasis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1997 | 1 | 1 | 2 |
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 2 | 4 |
| 2003 | 3 | 1 | 4 |
| 2004 | 3 | 1 | 4 |
| 2005 | 2 | 1 | 3 |
| 2006 | 2 | 1 | 3 |
| 2007 | 2 | 1 | 3 |
| 2008 | 4 | 0 | 4 |
| 2009 | 0 | 1 | 1 |
| 2010 | 2 | 1 | 3 |
| 2011 | 5 | 0 | 5 |
| 2012 | 3 | 0 | 3 |
| 2013 | 3 | 1 | 4 |
| 2014 | 3 | 1 | 4 |
| 2015 | 2 | 1 | 3 |
| 2016 | 5 | 1 | 6 |
| 2017 | 6 | 1 | 7 |
| 2018 | 6 | 0 | 6 |
| 2019 | 1 | 1 | 2 |
| 2020 | 5 | 1 | 6 |
| 2021 | 8 | 0 | 8 |
| 2022 | 12 | 0 | 12 |
| 2023 | 7 | 2 | 9 |
| 2024 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholestasis" by people in Profiles.
-
American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the management of chronic pancreatitis: summary and recommendations. Gastrointest Endosc. 2024 Oct; 100(4):584-594.
-
American Society for Gastrointestinal Endoscopy guideline on the role of therapeutic EUS in the management of biliary tract disorders: summary and recommendations. Gastrointest Endosc. 2024 Dec; 100(6):967-979.
-
Safety and efficacy of biliary suprapapillary metal and plastic stents in malignant biliary obstruction: a systematic review and meta-analysis. Surg Endosc. 2024 Aug; 38(8):4186-4197.
-
Diagnostic accuracy of serum matrix metalloproteinase-7 as a biomarker of biliary atresia in a large North American cohort. Hepatology. 2024 07 01; 80(1):152-162.
-
Neonatal cholestasis in children with Alpha-1-AT deficiency is a risk for earlier severe liver disease with male predominance. Hepatol Commun. 2023 12 01; 7(12).
-
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis. N Engl J Med. 2024 Feb 29; 390(9):795-805.
-
Sarcopenia is associated with osteopenia and impaired quality of life in children with genetic intrahepatic cholestatic liver disease. Hepatol Commun. 2023 11 01; 7(11).
-
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis. Aliment Pharmacol Ther. 2024 01; 59(2):186-200.
-
Cholestasis is associated with a higher rate of complications in both medical and surgical necrotizing enterocolitis. J Perinatol. 2024 01; 44(1):100-107.
-
Biliary atresia and liver transplantation in the United States: A contemporary analysis. Liver Int. 2023 10; 43(10):2198-2209.